Latest Gene silencing Stories
Findings may lead to novel treatments for diseases resistant to current RNAi
While examining patterns of DNA modification in lung cancer, a team of international researchers has discovered what they say is a surprising new mechanism.
Eric Selker's lab reports progress on biochemical communications among proteins involved in gene silencingResearchers in a University of Oregon lab have shed more light on the mechanism that regulates DNA methylation, a fundamental biological process in which a methyl group is attached to DNA, the genetic material in cells of living organisms.DNA methylation is essential for normal growth and development in plants and animals. It has been implicated in long-term memory, and irregularities in...
The Stowers Institute's Workman Lab has discovered a novel histone demethylase protein complex characterized in work published today in Molecular Cell.The Histone H3 protein is an important component of chromatin, the packing material wrapping up chromosomal DNA and preventing unwanted transcription of the message encoded in the DNA. Histone H3 can be altered by adding (methylating) or removing (demethylating) methyl groups from the histone protein. When genes are transcribed, parts of...
Plant researchers from McGill University and the University of California, Berkeley, have announced a major breakthrough in a developmental process called epigenetics.
Alnylam Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. (www.dicerna.com), a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology(TM), announced today the appointment of leading experts to its Scientific Advisory Board (SAB).
Dicerna Pharmaceuticals, Inc.
By Tuttle, John R Idris, A M; Brown, Judith K; Haigler, Candace H; Robertson, Dominique A silencing vector for cotton (Gossypium hirsutum) was developed from the geminivirus Cotton leaf crumple virus (CLCrV).
Dicerna Pharmaceuticals, Inc. (www.dicerna.com), a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology(TM), today announced key studies highlighting the therapeutic potential for Dicer-substrate small interfering RNAs (DsiRNAs).
- a slit in a tire to drain away surface water and improve traction.